Global private equity and venture capital news and research

By PE Sector

16 February 2012

Brazilian fund doubles up to meet institutional demand for green energyp

A Brazilian investment company is to double the size of its renewable energy fund as it aims to meet pension fund demand for the wind sector.

16 February 2012

IPO activity boosts Harbourvest funds

HarbourVest Private Equity, the listed fund of funds arm of HarbourVest Partners, saw its NAV rise again last month on the back of underlying stakes in floated investments such as Groupon and Zynga.

16 February 2012

Europe faces “pensions time-bomb”, EVCAp

The European Private Equity & Venture Capital Association has welcomed the proposals to review Europe’s retirement provision.

16 February 2012

JH Partners sells Australian skin care company Jurlique for $358m

San Francisco-based consumer-focused private equity firm JH Partners has sold Australian skin care company Jurlique International to listed Japanese rival Pola Orbis for an enterprise value of A$335m ($358m).

16 February 2012

Buy-out values, volumes rise for Canadian private equityp

Canadian private equity buy-outs enjoyed something of a recovery in 2011, with a record number of deals, and dollar amounts reaching the highest levels in three years.

16 February 2012

Israeli high-tech M&A up, IPOs on the declinep

telaviv_170sq Exits involving Israeli and related high-tech companies in 2011 totaled $5.23bn, while M&A deals were valued at $5.1bn, a massive 134 per cent increase on the $2.18bn recorded back in 2010.

16 February 2012

Hudson Clean Energy Partners takes stake in China’s GSE Investment

news_powerplant_lrg Private equity firm Hudson Clean Energy Partners has acquired a minority interest in China-based GSE Investment, an operator of solid waste-to-energy and water treatment projects.

15 February 2012

iNovia Capital adds entrepreneur in residence, venture partner

canada2_lrg Following the recent close of its third fund on C$110m, early stage venture firm iNovia Capital has added David Nault as entrepreneur in residence.

15 February 2012

Venture-backed medical device company EOS Imaging completes €38m IPO

Venture-backed medical device company EOS Imaging has raised €38m in its IPO on NYSE Euronext. Based on the opening trade price, the company is valued at approximately €120m.

15 February 2012

Biotech company Celladon seals $43m led by Pfizer Venture Investments

Biopharmaceutical company Celladon has completed a $43m equity financing led by corporate investment group Pfizer Venture Investments alongside new investors Lundbeckfond Ventures, Novartis Venture Funds, H&Q Healthcare/Life Sciences Investors, and GBS Venture Partners.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014